H.C. Wainwright lowered the firm’s price target on Inventiva to $13 from $14 and keeps a Buy rating on the shares after the company announced an immediate cash infusion of EUR 94.1M as part of a financing arrangement. The financing removes an “urgent and substantial financial overhang” on the shares, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IVA:
- Inventiva S.A. Plans Significant Capital Raise
- Inventiva announces financing of up to EUR 348M to advance NATiV3 Phase 3 study
- Sifel says financing should bring Inventiva’s Lani ‘over the finish line’
- Inventiva price target lowered to $14 from $22 at H.C. Wainwright
- Inventiva price target lowered to $20 from $25 at Stifel
